日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study

阐明仙灵慈芳颗粒抗乳腺癌的药理学基础：一项代谢组学分析研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S530516
Wang, Yang; Yang, Rui; Shi, Youyang; Liu, Sheng
肿瘤
肿瘤免疫
乳腺癌
代谢
发表日期：2025
文献求助 收藏

Spatial multi-omics analysis of tumor-stroma boundary cell features for predicting breast cancer progression and therapy response

利用空间多组学分析肿瘤-间质边界细胞特征，预测乳腺癌进展和治疗反应

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1570696
Wu, Yuanyuan; Shi, Youyang; Luo, Zhanyang; Zhou, Xiqiu; Chen, Yonghao; Song, Xiaoyun; Liu, Sheng
空间多组学
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2025
文献求助 收藏

Mediating effect of diabetes in the association between long-term PM(2.5) exposure and cancer risk in CHARLS

在CHARLS研究中，糖尿病在长期PM2.5暴露与癌症风险之间的关联中起中介作用。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-89885-2
Luo, Zhanyang; Sun, Yiqing; Tang, Haijia; Zhu, Bukun; Li, Xiang; Gong, Jingru; Shi, Youyang
糖尿病
肿瘤
肿瘤免疫
代谢
发表日期：2025
文献求助 收藏

Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer

研究三阴性乳腺癌的免疫原性细胞死亡依赖性亚型和预后特征

期刊:Phenomics
影响因子:6.2
doi:10.1007/s43657-023-00133-x
Shi, Youyang; Wu, Yuanyuan; Li, Feifei; Jiang, Kexin; Fang, Xiaofang; Wang, Yu; Song, Xiaoyun; Wang, Rui; Chen, Lixin; Zheng, Jinzhou; Wu, Chunyu; Qin, Yuenong; Liu, Xiaofei; Liu, Sheng
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Long-Term Outcomes of Traditional Chinese Medicine in the Treatment of Granulomatous Lobular Mastitis: A Two-Year Follow-Up Study on Recurrence and New Occurrence Rates with Analysis of Risk Factors

传统中医药治疗肉芽肿性小叶性乳腺炎的长期疗效：一项为期两年的复发率和新发率随访研究及风险因素分析

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S485589
Hua, Ciyi; Li, Feifei; Shi, Youyang; Xu, Yuan; Zhu, Mengdie; Wang, Yang; Zhou, Xiqiu; Liu, Sheng
炎症/感染
发表日期：2024
文献求助 收藏

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

仙灵连下方通过增强NK细胞介导的ADCC作用，提高曲妥珠单抗在HER2阳性乳腺癌中的疗效

期刊:
影响因子:
doi:10.1016/j.jpha.2024.100977
Li, Feifei; Shi, Youyang; Ma, Mei; Yang, Xiaojuan; Chen, Xiaosong; Xie, Ying; Liu, Sheng
细胞生物学
肿瘤
HER2
乳腺癌
肿瘤免疫
DCC
发表日期：2024
文献求助 收藏

Efficacy and safety of olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis of randomized controlled trials

奥拉帕尼联合阿比特龙治疗转移性去势抵抗性前列腺癌患者的疗效和安全性：随机对照试验的系统评价和荟萃分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1265276
Luo, Zhanyang; Zhu, Bukun; Xu, Hong; Chen, Lixin; Song, Xiaoyun; Wang, Yu; Wang, Rui; Zheng, Jinzhou; Qiu, Yunhua; Yang, Jianfeng; Shi, Youyang
前列腺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

[Retracted] Celastrus orbiculatus extracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells

【已撤稿】Celastrus orbiculatus提取物通过靶向人胃腺癌细胞中的maspin基因诱导细胞凋亡并抑制其侵袭

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2023.13919
Qian, Yayun; Lu, Songhua; Shi, Youyang; Zhao, Xueyu; Yang, Ting; Jin, Feng; Liu, Yanqing
凋亡
肿瘤
表观遗传
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment

膀胱癌中腺苷酸环化酶2甲基化的鉴定及其对预后和免疫抑制微环境的影响

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1025195
Yang, Jianfeng; Xu, Jin; Gao, Qian; Wu, Fan; Han, Wei; Yu, Chao; Shi, Youyang; Qiu, Yunhua; Chen, Yuanbiao; Zhou, Xiqiu
表观遗传
免疫/内分泌
肿瘤
肿瘤免疫
膀胱癌
发表日期：2022
文献求助 收藏

Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.

无水异柠檬酸苷通过增强 GPX1 表达抑制乳腺癌中的 EMT：基于测序技术和生物信息学分析的研究

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.764481
Li Feifei, Shi Youyang, Yang Xiaojuan, Luo Zhanyang, Zhang Guangtao, Yu Kui, Li Feng, Chen Lixin, Zhao Youkang, Xie Ying, Wu Yuanyuan, Yang Jianfeng, Zhou Xiqiu, Liu Sheng
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏